Plerixafor and resatorvid inhibit hepatitis B virus in vitro by upregulating elongation factor Tu GTP-binding domain containing 2

Plerixafor and resatorvid inhibit hepatitis B virus in vitro by upregulating elongation factor Tu GTP-binding domain containing 2

BackgroundAn increase in the demand for a functional cure has accelerated research on new methods of therapy for chronic hepatitis B, which is mainly focused on restoring antiviral immunity for controlling viral infections. Previously, we had described elongation factor Tu GTP-binding domain contain...

Full description

Bibliographic Details
Main Authors: Jinyuan Cai, Yuwen Li, Pingping Hu, Ruirui Xu, Hui Yuan, Wen Zhang, Tiantong Feng, Rui Liu, Wenting Li, Chuanlong Zhu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
hepatitis B virus
small-molecule agents
plerixafor
resatorvid
EFTUD2
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2023.1118801/full

Internet

https://www.frontiersin.org/articles/10.3389/fcimb.2023.1118801/full

Similar Items